SEGMENT INFORMATION

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

GE HealthCare’s operations are organized and managed through four reportable segments: Imaging, Ultrasound, Patient Care Solutions (“PCS”), and Pharmaceutical Diagnostics (“PDx”). These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments. A description of our reportable segments has been provided in the “Business” section of our Annual Report on Form 10-K for the year ended December 31, 2022.

The performance of these segments is principally measured based on Total revenues and an earnings metric defined as “Segment EBIT.” Segment EBIT is calculated as Income from continuing operations before income taxes in our Condensed Consolidated and Combined Statements of Income less the following: Interest and other financial charges – net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gains and losses of business and asset dispositions, Spin-Off and separation costs, amortization of acquisition-related intangible assets, and investment revaluation gains and losses.

Total Revenues by Segment
	For the three months ended June 30				For the six months ended June 30
	2023		2022		2023		2022
Imaging:
Radiology	$	2,227	$	2,064	$	4,315	$	3,982
Interventional Guidance	393		385		801		778
Total Imaging	2,620		2,449		5,116		4,760
Total Ultrasound	839		828		1,698		1,643
PCS:
Monitoring Solutions	563		512		1,115		1,033
Life Support Solutions	207		201		436		396
Total PCS	770		713		1,551		1,429
Total PDx	568		478		1,126		962
Other(a)	20		16		33		33
Total revenues	$	4,817	$	4,484	$	9,524	$	8,827

(a) Financial information not presented within the reportable segments, shown within the Other category, represents the HealthCare Financial Services (“HFS”) business which does not meet the definition of an operating segment.

Segment EBIT
	For the three months ended June 30				For the six months ended June 30
	2023		2022		2023		2022
Segment EBIT
Imaging	$	278	$	306	$	469	$	512
Ultrasound	191		220		398		412
PCS	84		81		193		146
PDx	152		115		307		253
Other(a)	6		(3)		8		(5)
	711		719		1,375		1,318
Restructuring costs	(19)		(10)		(31)		(22)
Acquisition and disposition-related benefits (charges)	2		(14)		1		(29)
Gain/(loss) of business and asset dispositions	—		—		—		3
Spin-Off and separation costs	(72)		—		(130)		—
Amortization of acquisition-related intangible assets	(32)		(30)		(63)		(63)
Investment revaluation gain (loss)	(6)		(14)		(1)		(22)
Interest and other financial charges – net	(137)		(12)		(273)		(16)
Non-operating benefit income (costs)	123		1		238		3
Income from continuing operations before income taxes	$	570	$	639	$	1,116	$	1,172

(a) Financial information not presented within the reportable segments, shown within the Other category, represents the HFS business and certain other business activities which do not meet the definition of an operating segment.